European Journal of Molecular & Clinical Medicine

Introduction- Schizophrenia is a chronic, multifaceted mental health illness marked
by a variety of symptoms, including delusions, hallucinations, disorganized speech
or behaviours, and cognitive impairment. The purpose of this study is to track and
evaluate the effects and results of schizophrenia disorder treatment.
Method- This prospective observational research was performed from December
2019 to December 2021. The study participants were patients suffering from
schizophrenia (according to DSM-5 criteria) who were treated at the tertiary care
centre, Overall, 62 patients were included in the study as cases according to
inclusion/exclusion criteria. Further, the demographic and clinical variables of
patients were collected with a personal information form.
Results- The mean age of the total enrolled cases was 49.62±5.87, with male
dominance was observed. Furthermore, in the case of FROGS SCALE, maximum
mean was reported for the category of the frogs general, i.e. 48.02±15.21and
minimum was observed for the category of Occupational functioning, i.e. 5.23±2.02.
In the case of WHOQOL-BREF SCALE maximum mean was reported for the
category of the Environment domain, i.e. 13.81±2.99 and the minimum was
observed for the category of Social domain, i.e. 10.76±3.80. Also, as per the MARS
Score, the mean with the range of 0-10 was 4.05±2.99, the median was 5 and the
interquartile range was 2-6. Lastly, the maximum mean was reported for the
category of the Environment domain, i.e. 26.23±4.87 and the minimum was observed
for the category of Social domain, i.e. 10.37±2.02, in the case of quality of life (QOL).
Conclusion- Our research reveals the strong association between QOL perception
and functional recovery in a group of schizophrenia patients with low levels of
functional recovery.